Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 11(1): 14965, 2021 07 22.
Article in English | MEDLINE | ID: mdl-34294758

ABSTRACT

The TRDC-locus encodes the T cell receptor delta constant region, one component of the γδ T cell receptor which is essential for development of γδ T cells. In contrast to peptide recognition by αß T cells, antigens activating γδ T cells are mostly MHC independent and not well characterized. Therefore, the function of γδ T cells and their contribution to protection against infections is still unclear. Higher numbers of circulating γδ T cells compared to mice, render the pig a suitable animal model to study γδ T cells. Knocking-out the porcine TRDC-locus by intracytoplasmic microinjection and somatic cell nuclear transfer resulted in healthy living γδ T cell deficient offspring. Flow cytometric analysis revealed that TRDC-KO pigs lack γδ T cells in peripheral blood mononuclear cells (PBMC) and spleen cells. The composition of the remaining leucocyte subpopulations was not affected by the depletion of γδ T cells. Genome-wide transcriptome analyses in PBMC revealed a pattern of changes reflecting the impairment of known or expected γδ T cell dependent pathways. Histopathology did not reveal developmental abnormalities of secondary lymphoid tissues. However, in a vaccination experiment the KO pigs stayed healthy but had a significantly lower neutralizing antibody titer as the syngenic controls.


Subject(s)
Gene Knockout Techniques/methods , Receptors, Antigen, T-Cell, gamma-delta/deficiency , T-Lymphocytes/immunology , Animals , Antibodies, Neutralizing/blood , Gene Expression Profiling , Gene Regulatory Networks , Leukocytes, Mononuclear/immunology , Mice , Nuclear Transfer Techniques , Spleen/immunology , Swine , Exome Sequencing
2.
Xenotransplantation ; 26(6): e12525, 2019 11.
Article in English | MEDLINE | ID: mdl-31119817

ABSTRACT

BACKGROUND: Despite major improvements in pig-to-primate xenotransplantation, long-term survival of xenografts is still challenging. The major histocompatibility complex (MHC) class I, which is crucial in cellular immune response, is an important xenoantigen. Abrogating MHC class I expression on xenografts might be beneficial for extending graft survival beyond current limits. METHODS: In this study, we employed the CRISPR/Cas9 system to target exon 2 of the porcine beta-2-microglobulin (B2M) gene to abrogate SLA class I expression on porcine cells. B2M-KO cells served as donor cells for somatic cell nuclear transfer, and cloned embryos were transferred to three recipient sows. The offspring were genotyped for mutations at the B2M locus, and blood samples were analyzed via flow cytometry for the absence of SLA class I molecules. RESULTS: Pregnancies were successfully established and led to the birth of seven viable piglets. Genomic sequencing proved that all piglets carried biallelic modifications at the B2M locus leading to a frameshift, a premature stop codon, and ultimately a functional knockout. However, survival times of these animals did not exceed 4 weeks due to unexpected disease processes. CONCLUSION: Here, we demonstrate the feasibility of generating SLA class I knockout pigs by targeting the porcine beta-2-microglobulin gene using the CRISPR/Cas9 system. Additionally, our findings indicate for the first time that this genetic modification might have a negative impact on the viability of the animals. These issues need to be solved to unveil the real value for xenotransplantation in the future.


Subject(s)
Galactosyltransferases/genetics , Histocompatibility Antigens Class I/genetics , Transplantation, Heterologous , beta 2-Microglobulin/genetics , Animals , Animals, Genetically Modified , CRISPR-Cas Systems , Female , Gene Knockout Techniques/methods , Nuclear Transfer Techniques , Pregnancy , Swine , Transplantation, Heterologous/methods
3.
Vet Microbiol ; 171(3-4): 406-12, 2014 Jul 16.
Article in English | MEDLINE | ID: mdl-24331744

ABSTRACT

Enteric red-mouth disease, caused by Yersinia ruckeri, is an important disease in rainbow trout aquaculture. Antimicrobial agents are frequently used in aquaculture, thereby causing a selective pressure on bacteria from aquatic organisms under which they may develop resistance to antimicrobial agents. In this study, the distribution of minimal inhibitory concentrations (MICs) of antimicrobial agents for 83 clinical and non-clinical epidemiologically unrelated Y. ruckeri isolates from north west Germany was determined. Antimicrobial susceptibility was conducted by broth microdilution at 22 ± 2°C for 24, 28 and 48 h. Incubation for 24h at 22 ± 2°C appeared to be suitable for susceptibility testing of Y. ruckeri. In contrast to other antimicrobial agents tested, enrofloxacin and nalidixic acid showed a bimodal distribution of MICs, with one subpopulation showing lower MICs for enrofloxacin (0.008-0.015 µg/mL) and nalidixic acid (0.25-0.5 µg/mL) and another subpopulation exhibiting elevated MICs of 0.06-0.25 and 8-64 µg/mL, respectively. Isolates showing elevated MICs revealed single amino acid substitutions in the quinolone resistance-determining region (QRDR) of the GyrA protein at positions 83 (Ser83-Arg or -Ile) or 87 (Asn87-Tyr), which raised the MIC values 8- to 32-fold for enrofloxacin or 32- to 128-fold for nalidixic acid. An isolate showing elevated MICs for sulfonamides and trimethoprim harbored a ∼ 8.9 kb plasmid, which carried the genes sul2, strB and a dfrA14 gene cassette integrated into the strA gene. These observations showed that Y. ruckeri isolates were able to develop mutations that reduce their susceptibility to (fluoro)quinolones and to acquire plasmid-borne resistance genes.


Subject(s)
Anti-Infective Agents/pharmacology , Drug Resistance, Bacterial/genetics , Fish Diseases/microbiology , Oncorhynchus mykiss/microbiology , Yersinia Infections/veterinary , Yersinia ruckeri/genetics , Animals , Aquaculture , DNA Gyrase/genetics , Drug Resistance, Bacterial/physiology , Enrofloxacin , Fluoroquinolones/pharmacology , Germany, West , Microbial Sensitivity Tests , Nalidixic Acid/pharmacology , Phenotype , Quinolones/pharmacology , Yersinia ruckeri/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...